Monday, September 11, 2023 2:45:56 PM
I always used their $82 million Astellas deal as a gauge.
That's coming up on a decade and things change but it was a benchmark.
Since then they've "worked" with Sanofi, eTheRNA, IO Biotech, etc. and a cast of others that followers have never heard the results from their efforts.
The patent with Catalent from MACAVIVA is solid but sits dormant.
Stallergenes approved the Anergis work but still chose to go with alum.
Asthma reduction is a big claim to be made public. No interest from big pharma?
Dr. Peter Hotez had a televised platform and captive audience for two years and never mentioned his MYMX work once.
PCI Biotech?
Were they actually even "working" with these companies?
Audited on taxes and got dropped by BDO. Mom and Pop accounting firm in Spokane, WA took over.
Longtime counsel Ernie Stern jumped ship.
The company that has them up "for sale" doesn't even list them on their web page.
Dr. Thomas Staehelin's run off to the wild, wild west (Serbia).
Mr. Kempers is at the pawn shop with office furniture.
Nobody has this bad of luck.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM